BUZZ-Valeant Pharmaceuticals International Inc: CEO says on road to recovery

Mon Jan 25, 2016 12:18pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 6 pct at $93.72

** Ailing Chief Executive, Michael Pearson, said he was on road to recovery but was uncertain when he would return from medical leave

** Pearson's illness capped a tumultuous year for Valeant as investors turned up pressure for Canadian drugmaker to provide more detailed plan on how it will increase profits in 2016

** Company also said FDA had accepted marketing application filed by partner AstraZeneca Plc for brodalumab injection, to treat patients with moderate-to-severe plaque psoriasis

** Valeant's stock had fallen 29 pct in 2015